Cleared Traditional

BIOMECHANICS FORCE PLATFORM/# OR6-5-1000 & 2000 (K883130) - FDA 510(k) Clearance

Class I Physical Medicine device.

K883130 · Advanced Mechanical Technology, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
90d
Days
Class 1
Risk

K883130 is an FDA 510(k) clearance for the BIOMECHANICS FORCE PLATFORM/# OR6-5-1000 & 2000. Classified as Platform, Force-measuring (product code KHX), Class I - General Controls.

Submitted by Advanced Mechanical Technology, Inc. (Newton, US). The FDA issued a Cleared decision on October 24, 1988 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.1575 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Advanced Mechanical Technology, Inc. devices

Submission Details

510(k) Number K883130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 1988
Decision Date October 24, 1988
Days to Decision 90 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 115d · This submission: 90d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KHX Platform, Force-measuring
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 890.1575
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.